Novel Racemases for Enzymatic Dynamic Kinetic Resolution

Information

  • Research Project
  • 6741792
  • ApplicationId
    6741792
  • Core Project Number
    R43CA106036
  • Full Project Number
    1R43CA106036-01
  • Serial Number
    106036
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/6/2004 - 20 years ago
  • Project End Date
    8/31/2004 - 20 years ago
  • Program Officer Name
    JONES, WARREN
  • Budget Start Date
    2/6/2004 - 20 years ago
  • Budget End Date
    8/31/2004 - 20 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    2/6/2004 - 20 years ago
Organizations

Novel Racemases for Enzymatic Dynamic Kinetic Resolution

DESCRIPTION (provided by applicant): Hydrolases are valuable industrial biocatalysts used to prepare optically pure compounds. Despite advantages, these enzymes are restricted to a maximum single pass product yield of 50% with racemic substrates. Substrate specific racemases offer the potential to achieve 100% yield without recycling if used in situ with hydrolases in dynamic kinetic resolutions. However, few examples of industrially appropriate racemases have been described. Ingenza proposes to use in vivo selections to isolate and develop novel racemases and establish dynamic kinetic resolution as a more general method for synthetic process chemistry. The initial focus will be the isolation of N-acylamino acid racemases for use with L- or D-aminoacylases to prepare unnatural amino acids and amines. Such compounds are requisites as synthons for antiviral and antineoplastic drugs. New pharmaceuticals from anticipated advances in proteomics will likely increase demand for this technology. Ingenza proposes to develop a toolbox of racemases and an efficient, scaleable technologyfor use in organic synthetic reactions. Phase I will show feasibility of the selective approach in isolating novel racemases. In Phase II we will optimize enzyme properties and application as applied biocatalysts. In Phase III, we will commercialize the technology for use by synthetic organic chemists and pharmaceutical manufacturers.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    INGENZA, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CHICAGO
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    60612
  • Organization District
    UNITED STATES